2021
DOI: 10.1088/1755-1315/711/1/012028
|View full text |Cite
|
Sign up to set email alerts
|

Potential of betacyanin as inhibitor of SARS-CoV-2 revealed by molecular docking study

Abstract: Covid-19 is a global pandemic where an effective drug has yet to be found. A new coronavirus species, SARS-CoV-2 causes this disease. Several studies have been conducted on medicinal plant-based lead compounds to find antidotes for this virus. One of the fruits that with a high betacyanin content is super red dragon fruit produced by plant Hylocereus costaricensis. Betacyanin, besides having anti-inflammatory and immunomodulatory activities, also has antiviral activity. Therefore, this study aimed to evaluate … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
4

Relationship

1
9

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…Coronaviruses belong to the family Coronaviridae, which is a family of enveloped single-stranded positive-sense RNA viruses. Therapeutic approaches such as neuraminidase inhibitors, nucleoside analogs, anti-inflammatory drugs, and antiviral drugs (e.g., remdesivir/lopinavir/ritonavir/nelfinavir/umifenovir/tenofovir disoproxil fumarate) have been suggested to treat COVID-19 [ 3 , 4 , 5 , 6 , 7 , 8 ]. Currently, more than 200 clinical trials analyzing these and other drugs have been registered on clinicaltrials.gov.…”
Section: Introductionmentioning
confidence: 99%
“…Coronaviruses belong to the family Coronaviridae, which is a family of enveloped single-stranded positive-sense RNA viruses. Therapeutic approaches such as neuraminidase inhibitors, nucleoside analogs, anti-inflammatory drugs, and antiviral drugs (e.g., remdesivir/lopinavir/ritonavir/nelfinavir/umifenovir/tenofovir disoproxil fumarate) have been suggested to treat COVID-19 [ 3 , 4 , 5 , 6 , 7 , 8 ]. Currently, more than 200 clinical trials analyzing these and other drugs have been registered on clinicaltrials.gov.…”
Section: Introductionmentioning
confidence: 99%
“…The formation of ligand-receptor complexes is mediated by molecular interactions such as hydrogen bonds, electrostatic interactions, and hydrophobic interactions (Tallei et al, 2021b). Figure 3 shows that androstan-17-one,3-ethyl-3-hydroxy-,(5.…”
Section: Resultsmentioning
confidence: 99%
“…Both compounds exhibit various interactions with the receptor -including van der Waals, alkyl, pi-alkyl, and unfavorable donors. The binding-free energy, hydrogen bonds, and other residual interactions are all parameters that affect how ligands and receptors interact (Tallei et al 2021b).…”
Section: Resultsmentioning
confidence: 99%